Armata Pharmaceuticals (ARMP) Capital Expenditures (2013 - 2026)
Armata Pharmaceuticals' Capital Expenditures came in at $17,000 for Q2 2026, down 88.6% from $149,000 a year earlier and down 73.0% from the prior quarter.
Armata Pharmaceuticals (ARMP) Capital Expenditures (2013 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Armata Pharmaceuticals reported Capital Expenditures of $374,000, down 26.8% year-over-year; for FY2025, it was $542,000, down 71.2% from FY2024.
- Capital Expenditures carries a five-year compound annual growth rate of -8.0% (FY2020 to FY2025).
- Going back by year, Capital Expenditures was $1.88 million in FY2024 (-76.9%), $8.14 million in FY2023 (+268.3%), $2.21 million in FY2022 (+69.6%) and $1.3 million in FY2021 (+58.3%).
- The Q2 2026 figure represents the lowest quarterly Capital Expenditures since Q4 2024.
- The fastest year-over-year change in Capital Expenditures over five years came in Q1 2023 (growth of 751.7%), and the weakest in Q3 2024 (a decline of 90.3%).
- Business Quant data shows ARMP's Capital Expenditures at $63,000 (Q1 2026), $52,000 (Q4 2025) and $242,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 1.32 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 322.00 Mn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 893.00 Mn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | -321.00 Mn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | -763.00 Mn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 513.00 Mn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 140.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 533.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 112.20 Mn |
| 10 | Armata Pharmaceuticals | 133.35 Mn | 81.07 Mn | - | 17,000.00 |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 17,000.00 |
| Mar 31, 2026 | 63,000.00 |
| Dec 31, 2025 | 52,000.00 |
| Sep 30, 2025 | 242,000.00 |
| Jun 30, 2025 | 149,000.00 |
| Mar 31, 2025 | 99,000.00 |
| Dec 31, 2024 | -77,000.00 |
| Sep 30, 2024 | 340,000.00 |
| Jun 30, 2024 | 1.37 Mn |
| Mar 31, 2024 | 250,000.00 |
| Dec 31, 2023 | 2.40 Mn |
| Sep 30, 2023 | 3.51 Mn |
| Jun 30, 2023 | 222,000.00 |
| Mar 31, 2023 | 2.01 Mn |
| Dec 31, 2022 | -455,000.00 |
| Sep 30, 2022 | 1.29 Mn |
| Jun 30, 2022 | 1.14 Mn |
| Mar 31, 2022 | 236,000.00 |
| Dec 31, 2021 | 228,000.00 |
| Sep 30, 2021 | 582,000.00 |
Armata Pharmaceuticals Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=ARMP&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "ARMP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=ARMP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();